← Leaderboards
Michael D. Weiden
New York University School Of Medicine
$9,969,115
Attributed
$9,969,115
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $970.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$5,283,401 · 4
NIH$4,685,714 · 6
By mechanism
U01$5,020,670 · 3
R01$3,751,993 · 1
K24$868,396 · 1
R21$262,731 · 1
M01$65,325 · 4
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- William N Rom$26,662,104
- Leopoldo Nicolas Segal$9,785,416
- Lung-Chi Chen$3,621,297
- Jeffrey N. Weiser$24,184,462
- Michael L Dustin$32,535,535
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisLungTranscription FactorHiv InfectionsMacrophageClinical ResearchAlveolar MacrophagesHuman SubjectVirus ReplicationInfectionHiv-1CellsMutationProductionCytokineViralGenetic TranscriptionLaboratoriesAcquired Immunodeficiency SyndromeSiteRecruitment ActivityOpportunistic InfectionsRestBronchoalveolar Lavage
Grant awards (32)
FEV1 Variability as a Novel Mortality Biomarker$262,731
R21 · FY2025 · OH · contact PI
Treatment response of WTC related airway injury$794,957
U01 · FY2020 · OH · contact PI
Treatment response of WTC related airway injury$785,272
U01 · FY2019 · OH · contact PI
Evolution of risk factors for lung function decline in WTC exposed firefighters$500,000
U01 · FY2018 · OH · contact PI
Evolution of risk factors for lung function decline in WTC exposed firefighters$500,000
U01 · FY2017 · OH · contact PI
Evolution of risk factors for lung function decline in WTC exposed firefighters$500,000
U01 · FY2016 · OH · contact PI
Evolution of Risk Factors for Sinusitis in WTC Exposed Firefighters$969,693
U01 · FY2015 · OH · contact PI
Evolution of Risk Factors for Sinusitis in WTC Exposed Firefighters$970,748
U01 · FY2014 · OH · contact PI
HIV activation in secondary pulmonary infection$147,450
K24 · FY2013 · AI · contact PI
HIV activation in secondary pulmonary infection$147,450
K24 · FY2012 · AI · contact PI
HIV activation in secondary pulmonary infection$147,450
K24 · FY2011 · AI · contact PI
HIV activation in secondary pulmonary infection$144,689
K24 · FY2010 · AI · contact PI
HIV activation in secondary pulmonary infection$141,989
K24 · FY2009 · AI · contact PI
HIV/TB Interaction in the Lung$482,892
R01 · FY2008 · HL · contact PI
HIV activation in secondary pulmonary infection$139,368
K24 · FY2008 · AI · contact PI
HIV/TB INTERACTION IN THE LUNG$955
M01 · FY2008 · RR · contact PI
HIV/TB Interaction in the Lung$468,819
R01 · FY2007 · HL · contact PI
HIV/TB Interaction in the Lung$468,751
R01 · FY2006 · HL · contact PI
HIV/TB INTERACTION IN THE LUNG$33,435
M01 · FY2006 · RR · contact PI
HIV/TB Interaction in the Lung$466,041
R01 · FY2005 · HL
HIV/TB INTERACTION IN THE LUNG$9,019
M01 · FY2005 · RR
HIV/TB Interaction in the Lung$452,468
R01 · FY2004 · HL
HIV/TB Interaction In The Lung$791
M01 · FY2004 · RR
Functional Genomics of Interferon for Tuberculosis$119
M01 · FY2004 · RR
HIV/TB INTERACTION IN THE LUNG$368,514
R01 · FY2003 · HL
HIV/TB INTERACTION IN THE LUNG$358,510
R01 · FY2002 · HL
HIV &TB INTERACTION IN LUNG$0
M01 · FY2002 · RR
HIV/TB INTERACTION IN THE LUNG$348,068
R01 · FY2001 · HL
HIV &TB INTERACTION IN LUNG$0
M01 · FY2001 · RR
HIV/TB INTERACTION IN THE LUNG$337,930
R01 · FY2000 · HL
HIV &TB INTERACTION IN LUNG$21,006
M01 · FY2000 · RR
HIV &TB INTERACTION IN LUNG$0
M01 · FY2000 · RR